The Boeing Company (BA) Forms $344.19 Double Top; Last Week VIVUS, Inc. (VVUS) Coverage

The Boeing Company (BA) formed double top with $368.28 target or 7.00% above today’s $344.19 share price. The Boeing Company (BA) has $202.55 billion valuation. The stock decreased 2.91% or $10.33 during the last trading session, reaching $344.19. About 6.09 million shares traded or 10.60% up from the average. The Boeing Company (NYSE:BA) has risen 41.13% since March 13, 2017 and is uptrending. It has outperformed by 24.43% the S&P500.

Among 2 analysts covering Vivus (NASDAQ:VVUS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vivus had 3 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, July 31. The stock has “Hold” rating by Zacks on Wednesday, August 5. WallachBeth Capital upgraded it to “Buy” rating and $2.80 target in Thursday, November 5 report. See VIVUS, Inc. (NASDAQ:VVUS) latest ratings:

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company has market cap of $62.26 million. The firm offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 or greater, or 27 or greater in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol; and STENDRA, an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. It has a 1.73 P/E ratio. It is also developing Qsymia, which has completed Phase II studies for the treatment of obstructive sleep apnea and diabetes, as well as for other obesity-related diseases, including nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, hyperlipidemia, and hypertension.

Investors sentiment increased to 0.57 in 2017 Q3. Its up 0.04, from 0.53 in 2017Q2. It increased, as 12 investors sold VIVUS, Inc. shares while 22 reduced holdings. 5 funds opened positions while 13 raised stakes. 32.65 million shares or 13.20% less from 37.61 million shares in 2017Q2 were reported. Sei Investments invested 0% of its portfolio in VIVUS, Inc. (NASDAQ:VVUS). Nine Chapters Management Limited Com has invested 0.2% in VIVUS, Inc. (NASDAQ:VVUS). Sg Americas Limited Liability Com stated it has 0% of its portfolio in VIVUS, Inc. (NASDAQ:VVUS). Art Advsrs Lc has 84,894 shares. 3.49M are held by Vanguard Grp Inc. Winfield Associates Inc accumulated 0% or 400 shares. Menta Capital Ltd Liability Company stated it has 0.02% in VIVUS, Inc. (NASDAQ:VVUS). Connor Clark & Lunn Ltd stated it has 0% in VIVUS, Inc. (NASDAQ:VVUS). D E Shaw And Com owns 432,866 shares for 0% of their portfolio. Next Gru reported 4,253 shares or 0% of all its holdings. Renaissance Technologies Ltd owns 8.67M shares for 0.01% of their portfolio. Bancorporation Of Montreal Can invested in 110,000 shares or 0% of the stock. Royal Bancorp Of Canada reported 0% in VIVUS, Inc. (NASDAQ:VVUS). Citadel Advsrs Ltd Liability Co has invested 0% in VIVUS, Inc. (NASDAQ:VVUS). 11,000 are held by Schulhoff.

The stock increased 19.92% or $0.0976 during the last trading session, reaching $0.5876. About 2.97M shares traded or 323.26% up from the average. VIVUS, Inc. (NASDAQ:VVUS) has declined 7.14% since March 13, 2017 and is downtrending. It has underperformed by 23.84% the S&P500.

Investors sentiment decreased to 0.79 in 2017 Q3. Its down 0.02, from 0.81 in 2017Q2. It turned negative, as 50 investors sold The Boeing Company shares while 609 reduced holdings. 165 funds opened positions while 367 raised stakes. 411.79 million shares or 1.95% less from 419.99 million shares in 2017Q2 were reported. Markel holds 0.48% or 94,400 shares. Palo accumulated 5,286 shares or 0.71% of the stock. Park Natl Corp Oh invested in 0.14% or 9,585 shares. Stanley reported 0.67% stake. Ardevora Asset Llp holds 0.71% of its portfolio in The Boeing Company (NYSE:BA) for 93,500 shares. Jones Fin Cos Lllp holds 0% of its portfolio in The Boeing Company (NYSE:BA) for 2,710 shares. Earnest Partners Ltd Llc has invested 0.36% in The Boeing Company (NYSE:BA). Glovista Invs Ltd Liability Corp has invested 0.04% in The Boeing Company (NYSE:BA). First Natl Com accumulated 31,860 shares or 0.94% of the stock. Intact Invest holds 0.39% or 35,750 shares. Bowling Portfolio Management Limited holds 26,143 shares. 3,490 are owned by Campbell Newman Asset Mgmt. 20,164 are held by Windward Ca. Winslow Evans Crocker invested in 0.32% or 3,766 shares. Peregrine Asset Advisers has invested 0.97% of its portfolio in The Boeing Company (NYSE:BA).

Among 25 analysts covering Boeing (NYSE:BA), 17 have Buy rating, 1 Sell and 7 Hold. Therefore 68% are positive. Boeing has $470.0 highest and $125 lowest target. $335.18’s average target is -2.62% below currents $344.19 stock price. Boeing had 104 analyst reports since August 26, 2015 according to SRatingsIntel. On Monday, January 8 the stock rating was maintained by Canaccord Genuity with “Hold”. The stock of The Boeing Company (NYSE:BA) has “Buy” rating given on Tuesday, January 16 by Robert W. Baird. As per Wednesday, November 15, the company rating was maintained by RBC Capital Markets. Wells Fargo maintained the stock with “Hold” rating in Tuesday, December 12 report. Seaport Global maintained the stock with “Buy” rating in Wednesday, January 17 report. As per Thursday, July 27, the company rating was upgraded by Credit Suisse. Robert W. Baird maintained The Boeing Company (NYSE:BA) on Thursday, July 27 with “Buy” rating. RBC Capital Markets maintained The Boeing Company (NYSE:BA) rating on Thursday, April 27. RBC Capital Markets has “Underperform” rating and $146 target. The rating was initiated by Berenberg with “Buy” on Wednesday, March 29. The stock of The Boeing Company (NYSE:BA) earned “Sector Perform” rating by RBC Capital Markets on Thursday, April 28.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: